Could more complex molecular analysis aid biomarker-driven clinical management of poor-prognosis colorectal cancer?
Treatment duration of immunotherapy combination does not impact on disease-free survival in dMMR colon cancer
Adagrasib plus cetuximab fails to outperform chemotherapy in KRAS G12C-mutated metastatic colorectal cancer
Early-phase studies point to efficacy of a nectin-4-targeting antibody-drug conjugate in cervical cancer
First-line dual targeting combination shows encouraging, durable responses in triple-negative breast cancer